Compare J.B.Chemicals with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs TORRENT PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS TORRENT PHARMA J.B.CHEMICALS/
TORRENT PHARMA
 
P/E (TTM) x 22.6 38.2 59.0% View Chart
P/BV x 4.1 8.3 48.9% View Chart
Dividend Yield % 0.3 0.7 39.5%  

Financials

 J.B.CHEMICALS   TORRENT PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
TORRENT PHARMA
Mar-19
J.B.CHEMICALS/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3631,964 18.5%   
Low Rs2551,245 20.5%   
Sales per share (Unadj.) Rs169.1453.4 37.3%  
Earnings per share (Unadj.) Rs16.625.8 64.4%  
Cash flow per share (Unadj.) Rs23.462.3 37.6%  
Dividends per share (Unadj.) Rs2.0017.00 11.8%  
Dividend yield (eoy) %0.61.1 61.1%  
Book value per share (Unadj.) Rs172.5279.2 61.8%  
Shares outstanding (eoy) m83.57169.22 49.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.83.5 51.6%   
Avg P/E ratio x18.662.2 29.9%  
P/CF ratio (eoy) x13.225.8 51.2%  
Price / Book Value ratio x1.85.7 31.2%  
Dividend payout %12.065.9 18.3%   
Avg Mkt Cap Rs m25,827271,513 9.5%   
No. of employees `0003.813.6 27.7%   
Total wages/salary Rs m2,51114,038 17.9%   
Avg. sales/employee Rs Th3,747.45,642.6 66.4%   
Avg. wages/employee Rs Th665.71,032.4 64.5%   
Avg. net profit/employee Rs Th367.8320.9 114.6%   
INCOME DATA
Net Sales Rs m14,13576,728 18.4%  
Other income Rs m366571 64.1%   
Total revenues Rs m14,50177,299 18.8%   
Gross profit Rs m2,17819,831 11.0%  
Depreciation Rs m5706,177 9.2%   
Interest Rs m355,038 0.7%   
Profit before tax Rs m1,9409,187 21.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m5521,254 44.1%   
Profit after tax Rs m1,3874,363 31.8%  
Gross profit margin %15.425.8 59.6%  
Effective tax rate %28.513.6 208.7%   
Net profit margin %9.85.7 172.6%  
BALANCE SHEET DATA
Current assets Rs m10,47050,375 20.8%   
Current liabilities Rs m2,74951,653 5.3%   
Net working cap to sales %54.6-1.7 -3,279.9%  
Current ratio x3.81.0 390.5%  
Inventory Days Days5592 60.0%  
Debtors Days Days7868 113.7%  
Net fixed assets Rs m5,81183,648 6.9%   
Share capital Rs m167846 19.7%   
"Free" reserves Rs m14,24846,397 30.7%   
Net worth Rs m14,41647,244 30.5%   
Long term debt Rs m039,129 0.0%   
Total assets Rs m17,649141,209 12.5%  
Interest coverage x56.62.8 2,003.5%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x0.80.5 147.4%   
Return on assets %8.16.7 121.0%  
Return on equity %9.69.2 104.2%  
Return on capital %13.712.3 111.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16422,103 27.9%   
Fx outflow Rs m1,3345,522 24.2%   
Net fx Rs m4,82916,581 29.1%   
CASH FLOW
From Operations Rs m1,23117,981 6.8%  
From Investments Rs m-208-2,413 8.6%  
From Financial Activity Rs m-595-13,145 4.5%  
Net Cashflow Rs m4272,380 17.9%  

Share Holding

Indian Promoters % 55.4 71.5 77.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 7.0 48.3%  
FIIs % 3.9 12.6 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.8 420.5%  
Shareholders   30,437 26,511 114.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Over 750 Points Higher; Banking Stocks Rally(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 1.4% while the Hang Seng is up 3.1%.

Related Views on News

J.B.CHEMICALS at All Time High; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Jun 1, 2020 | Updated on Jun 1, 2020

J.B.CHEMICALS share price has hit an all time high at Rs 707 (down 0.3%). The BSE HEALTHCARE Index is up by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are J.B.CHEMICALS (down 0.3%) and ABBOTT INDIA (up 0.3%). The top losers include AUROBINDO PHARMA (down 0.2%) and SUN PHARMA (down 0.2%).

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 1, 2020 10:33 AM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS